Tokyo Tape
Sign in
← Sakai Chemical Industry

Half-year report · Q2

4078.TEDINET S100UO2I
Period2024-04-01 → 2024-09-30
Filed2024-11-08
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed

Amended by S100V7D8 (2025-02-07).

Key figures · 45
MetricValuePeriodScopeSource row
Revenue¥41.9bn2024-04-01 → 2024-09-30Cons.Net sales
Revenue¥82.1bn2023-04-01 → 2024-03-31Cons.Net sales (5-year summary)
Revenue¥40.5bn2023-04-01 → 2023-09-30Cons.Net sales
Operating income¥2.6bn2024-04-01 → 2024-09-30Cons.Operating income
Operating income¥917m2023-04-01 → 2023-09-30Cons.Operating income
Ordinary income¥2.6bn2024-04-01 → 2024-09-30Cons.Ordinary income
Ordinary income¥3.1bn2023-04-01 → 2024-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥885m2023-04-01 → 2023-09-30Cons.Ordinary income
Profit before tax¥2.4bn2024-04-01 → 2024-09-30Cons.Income before income taxes
Profit before tax¥773m2023-04-01 → 2023-09-30Cons.Income before income taxes
Net income (owners)¥1.7bn2024-04-01 → 2024-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)−¥7.1bn2023-04-01 → 2024-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)−¥2.0bn2023-04-01 → 2023-09-30Cons.Profit loss attributable to owners of parent
Net income¥1.8bn2024-04-01 → 2024-09-30Cons.Profit loss
Net income−¥1.8bn2023-04-01 → 2023-09-30Cons.Profit loss
Total assets¥121.2bnat 2024-09-30Cons.Assets
Total assets¥125.4bnat 2024-03-31Cons.Assets
Total assets¥131.6bnat 2023-09-30Cons.Total assets (5-year summary)
Total liabilities¥44.1bnat 2024-09-30Cons.Liabilities
Total liabilities¥50.0bnat 2024-03-31Cons.Liabilities
Net assets / equity¥77.1bnat 2024-09-30Cons.Net assets
Net assets / equity¥75.5bnat 2024-03-31Cons.Net assets
Net assets / equity¥80.7bnat 2023-09-30Cons.Net assets (5-year summary)
Cash and deposits¥14.8bnat 2024-09-30Cons.Cash and deposits
Cash and deposits¥16.6bnat 2024-03-31Cons.Cash and deposits
Cash & equivalents¥14.6bnat 2024-09-30Cons.Cash and cash equivalents
Cash & equivalents¥16.5bnat 2024-03-31Cons.Cash and cash equivalents
Cash & equivalents¥15.5bnat 2023-09-30Cons.Cash and cash equivalents
Cash & equivalents¥12.2bnat 2023-03-31dCons.Cash and cash equivalents
Operating cash flow¥7.4bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥6.9bn2023-04-01 → 2024-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥3.2bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥3.0bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥4.0bn2023-04-01 → 2024-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥1.6bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥6.6bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in financing activities
Financing cash flow¥1.3bn2023-04-01 → 2024-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow¥1.6bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥107.712024-04-01 → 2024-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-437.652023-04-01 → 2024-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-125.532023-04-01 → 2023-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥97.232024-04-01 → 2024-09-30Cons.Diluted earnings per share (5-year summary)
Equity ratio62.7%at 2024-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio59.3%at 2024-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio60.5%at 2023-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 30
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2024-04-01 → 2024-09-30−¥910m
Reconciling Itemsreconcilingrevenue intersegment2024-04-01 → 2024-09-30−¥910m
Reconciling Itemsreconcilingsegment profit2024-04-01 → 2024-09-30−¥1.2bn
jpcrp040300-q2r_E00780-000Chemicalreportable segmentrevenue2024-04-01 → 2024-09-30¥38.4bn
jpcrp040300-q2r_E00780-000Chemicalreportable segmentrevenue external2024-04-01 → 2024-09-30¥37.6bn
jpcrp040300-q2r_E00780-000Chemicalreportable segmentrevenue intersegment2024-04-01 → 2024-09-30¥798m
jpcrp040300-q2r_E00780-000Chemicalreportable segmentsegment profit2024-04-01 → 2024-09-30¥3.8bn
jpcrp040300-q2r_E00780-000Medicine And Health Carereportable segmentrevenue2024-04-01 → 2024-09-30¥4.4bn
jpcrp040300-q2r_E00780-000Medicine And Health Carereportable segmentrevenue external2024-04-01 → 2024-09-30¥4.3bn
jpcrp040300-q2r_E00780-000Medicine And Health Carereportable segmentrevenue intersegment2024-04-01 → 2024-09-30¥111m
jpcrp040300-q2r_E00780-000Medicine And Health Carereportable segmentsegment profit2024-04-01 → 2024-09-30¥65m
—segment totalrevenue2024-04-01 → 2024-09-30¥42.8bn
—segment totalrevenue external2024-04-01 → 2024-09-30¥41.9bn
—segment totalrevenue intersegment2024-04-01 → 2024-09-30¥910m
—segment totalsegment profit2024-04-01 → 2024-09-30¥3.8bn
Reconciling Itemsreconcilingrevenue2023-04-01 → 2023-09-30−¥635m
Reconciling Itemsreconcilingrevenue intersegment2023-04-01 → 2023-09-30−¥635m
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-09-30−¥1.1bn
jpcrp040300-q2r_E00780-000Chemicalreportable segmentrevenue2023-04-01 → 2023-09-30¥36.8bn
jpcrp040300-q2r_E00780-000Chemicalreportable segmentrevenue external2023-04-01 → 2023-09-30¥36.3bn
jpcrp040300-q2r_E00780-000Chemicalreportable segmentrevenue intersegment2023-04-01 → 2023-09-30¥498m
jpcrp040300-q2r_E00780-000Chemicalreportable segmentsegment profit2023-04-01 → 2023-09-30¥1.9bn
jpcrp040300-q2r_E00780-000Medicine And Health Carereportable segmentrevenue2023-04-01 → 2023-09-30¥4.3bn
jpcrp040300-q2r_E00780-000Medicine And Health Carereportable segmentrevenue external2023-04-01 → 2023-09-30¥4.2bn
jpcrp040300-q2r_E00780-000Medicine And Health Carereportable segmentrevenue intersegment2023-04-01 → 2023-09-30¥136m
jpcrp040300-q2r_E00780-000Medicine And Health Carereportable segmentsegment profit2023-04-01 → 2023-09-30¥144m
—segment totalrevenue2023-04-01 → 2023-09-30¥41.1bn
—segment totalrevenue external2023-04-01 → 2023-09-30¥40.5bn
—segment totalrevenue intersegment2023-04-01 → 2023-09-30¥635m
—segment totalsegment profit2023-04-01 → 2023-09-30¥2.0bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 516
ItemContextValueUnit
Allowance for doubtful accounts caPrior1YearInstant-28000000JPY
Allowance for doubtful accounts caCurrentQuarterInstant-21000000JPY
Current assetsPrior1YearInstant76042000000JPY
Current assetsCurrentQuarterInstant70276000000JPY
Buildings and structures netPrior1YearInstant15648000000JPY
Buildings and structures netCurrentQuarterInstant16665000000JPY
Machinery equipment and vehicles netPrior1YearInstant7666000000JPY
Machinery equipment and vehicles netCurrentQuarterInstant7667000000JPY
Tools furniture and fixtures netPrior1YearInstant1108000000JPY
Tools furniture and fixtures netCurrentQuarterInstant1310000000JPY
LandPrior1YearInstant13305000000JPY
LandCurrentQuarterInstant13368000000JPY
Construction in progressPrior1YearInstant2733000000JPY
Construction in progressCurrentQuarterInstant3839000000JPY
Property plant and equipmentPrior1YearInstant40463000000JPY
Property plant and equipmentCurrentQuarterInstant42852000000JPY
GoodwillPrior1YearInstant888000000JPY
GoodwillCurrentQuarterInstant832000000JPY
Other iaPrior1YearInstant280000000JPY
Other iaCurrentQuarterInstant266000000JPY
Intangible assetsPrior1YearInstant1168000000JPY
Intangible assetsCurrentQuarterInstant1099000000JPY
Investment securitiesPrior1YearInstant6206000000JPY
Investment securitiesCurrentQuarterInstant5549000000JPY
Net defined benefit assetPrior1YearInstant104000000JPY
Net defined benefit assetCurrentQuarterInstant107000000JPY
Deferred tax assetsPrior1YearInstant886000000JPY
Deferred tax assetsCurrentQuarterInstant904000000JPY
Other ioaPrior1YearInstant586000000JPY
Other ioaCurrentQuarterInstant487000000JPY
Allowance for doubtful accounts ioa by groupPrior1YearInstant-12000000JPY
Allowance for doubtful accounts ioa by groupCurrentQuarterInstant-31000000JPY
Investments and other assetsPrior1YearInstant7770000000JPY
Investments and other assetsCurrentQuarterInstant7017000000JPY
Noncurrent assetsPrior1YearInstant49402000000JPY
Noncurrent assetsCurrentQuarterInstant50969000000JPY
AssetsPrior1YearInstant125445000000JPY
AssetsCurrentQuarterInstant121246000000JPY
Notes and accounts payable tradePrior1YearInstant9066000000JPY
Notes and accounts payable tradeCurrentQuarterInstant9026000000JPY
Short term loans payablePrior1YearInstant15108000000JPY
Short term loans payableCurrentQuarterInstant9014000000JPY
Income taxes payablePrior1YearInstant576000000JPY
Income taxes payableCurrentQuarterInstant884000000JPY
Provision for bonusesPrior1YearInstant1286000000JPY
Provision for bonusesCurrentQuarterInstant1293000000JPY
Other provision clPrior1YearInstant39000000JPY
Other provision clCurrentQuarterInstant55000000JPY
Other clPrior1YearInstant5679000000JPY
Other clCurrentQuarterInstant5481000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2024-03-31pass rounding
balance sheet identityconsolidated 2024-09-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2024-03-31pass
statement vs summary · net assetsconsolidated 2024-09-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2024-04-01/2024-09-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-09-30pass
statement vs summary · operating cash flowconsolidated 2024-04-01/2024-09-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-09-30pass
statement vs summary · revenueconsolidated 2024-04-01/2024-09-30pass
statement vs summary · total assetsconsolidated 2024-03-31pass
statement vs summary · total assetsconsolidated 2024-09-30pass